For example, nanoparticles conjugated with siRNA targeting the oncogene Bcl-2 have been shown to selectively inhibit the growth of cancer cells overexpressing Bcl-2, resulting in improved cancer treatment efficacy (Rahman et al., 2018). The gene discussed is BCL2; the disease is cancer.